Indivior up as it hits back at claims

FTSE 250 pharmaceuticals firm Indivior (LON:INDV) watched its share price rise by 2.46% to 102.20p (as of 14:15 GMT) after replying to press reports. It has been claimed that Reckitt Benckiser will file legal claims against the company, but management said that they believe the case is without merit and that they have strong grounds to defend against it.

Further information will be made available as the situation develops.